July 21, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Relypsa Inc (NASDAQ:RLYP), was announced concerning whether the takeover of Relypsa Inc. by Galenica Group for $32.00 per share is unfair to NASDAQ:RLYP stockholders.

The investigation by a law firm concerns whether certain officers and directors of Relypsa Inc breached their fiduciary duties owed to NASDAQ:RLYP investors in connection with the proposed acquisition.

On July 21, 2016, Galenica Group (SIX:GALN) and Relypsa, Inc.(NASDAQ:RLYP) announced that the companies have entered into an agreement under which Galenica Group will acquire Relypsa Inc (NASDAQ:RLYP). Under the terms of the merger agreement, Galenica will pay $32 per share in cash, or a total of approximately$1.53 billion.

However, given that at least one analyst has set the high target price for NASDAQ:RLYP shares at $51.00 per share, the investigation concerns whether the offer is unfair to NASDAQ:RLYP stockholders. More specifically, the investigation concerns whether the Relypsa Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.